These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 20537635)

  • 1. Gene expression signatures of breast tissue before and after cross-sex hormone therapy in female-to-male transsexuals.
    Bentz EK; Pils D; Bilban M; Kaufmann U; Hefler LA; Reinthaller A; Singer CF; Huber JC; Horvat R; Tempfer CB
    Fertil Steril; 2010 Dec; 94(7):2688-96. PubMed ID: 20537635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population.
    Grynberg M; Fanchin R; Dubost G; Colau JC; Brémont-Weil C; Frydman R; Ayoubi JM
    Reprod Biomed Online; 2010 Apr; 20(4):553-8. PubMed ID: 20122869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex reassignment therapy in gender identity disorders.
    Money J
    Int Psychiatry Clin; 1971; 8(4):197-210. PubMed ID: 5155164
    [No Abstract]   [Full Text] [Related]  

  • 4. Handedness, functional cerebral hemispheric lateralization, and cognition in male-to-female transsexuals receiving cross-sex hormone treatment.
    Wisniewski AB; Prendeville MT; Dobs AS
    Arch Sex Behav; 2005 Apr; 34(2):167-72. PubMed ID: 15803250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
    Asscheman H; Giltay EJ; Megens JA; de Ronde WP; van Trotsenburg MA; Gooren LJ
    Eur J Endocrinol; 2011 Apr; 164(4):635-42. PubMed ID: 21266549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist.
    Dittrich R; Binder H; Cupisti S; Hoffmann I; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):586-92. PubMed ID: 16320157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sex hormone administration changes pain in transsexual women and men.
    Aloisi AM; Bachiocco V; Costantino A; Stefani R; Ceccarelli I; Bertaccini A; Meriggiola MC
    Pain; 2007 Nov; 132 Suppl 1():S60-S67. PubMed ID: 17379410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects.
    Giltay EJ; Kho KH; Blansjaar BA; Verbeek MM; Geurtz PB; Geleijnse JM; Gooren LJ
    J Endocrinol; 2005 Oct; 187(1):109-16. PubMed ID: 16214946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sex hormone therapy alters the serum lipid profile: a retrospective cohort study in 169 transsexuals.
    Ott J; Aust S; Promberger R; Huber JC; Kaufmann U
    J Sex Med; 2011 Aug; 8(8):2361-9. PubMed ID: 21595834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profound Changes in Sex Hormone Levels during Cross-Sex Hormone Therapy of Transsexuals do not Alter Serum Cholesterol Acceptor Capacity.
    Wultsch A; Kaufmann U; Ott J; Stojakovic T; Scharnagl H; Stangl H; Strobl WM
    J Sex Med; 2015 Jun; 12(6):1436-9. PubMed ID: 25854918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term androgen administration on breast tissue of female-to-male transsexuals.
    Slagter MH; Gooren LJ; Scorilas A; Petraki CD; Diamandis EP
    J Histochem Cytochem; 2006 Aug; 54(8):905-10. PubMed ID: 16618941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones.
    Mueller A; Gooren L
    Eur J Endocrinol; 2008 Sep; 159(3):197-202. PubMed ID: 18567667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals.
    Elbers JM; de Jong S; Teerlink T; Asscheman H; Seidell JC; Gooren LJ
    Metabolism; 1999 Nov; 48(11):1371-7. PubMed ID: 10582544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist.
    Mueller A; Zollver H; Kronawitter D; Oppelt PG; Claassen T; Hoffmann I; Beckmann MW; Dittrich R
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):95-100. PubMed ID: 20625973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals.
    Elbers JM; Asscheman H; Seidell JC; Frölich M; Meinders AE; Gooren LJ
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3267-70. PubMed ID: 9329351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morbidity in transsexual patients with cross-gender hormone self-treatment].
    Becerra Fernández A; de Luis Román DA; Piédrola Maroto G
    Med Clin (Barc); 1999 Oct; 113(13):484-7. PubMed ID: 10604171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects.
    Giltay EJ; Bunck MC; Gooren LJ; Zitman FG; Diamant M; Teerlink T
    Neuroendocrinology; 2008; 88(2):103-10. PubMed ID: 18511863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening.
    Fledderus AC; Gout HA; Ogilvie AC; van Loenen DKG
    Breast; 2020 Oct; 53():92-100. PubMed ID: 32679529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness.
    Pedraza V; Gomez-Capilla JA; Escaramis G; Gomez C; Torné P; Rivera JM; Gil A; Araque P; Olea N; Estivill X; Fárez-Vidal ME
    Cancer; 2010 Jan; 116(2):486-96. PubMed ID: 20029976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.